Evidence map›Paper›PMID 42122629›Full record

ArticleSensors (Basel, Switzerland)2026

A High-Sensitivity Sweat Glucose Biosensor Enabled by an In Situ Grown NiFe PBA on Porous Pt/Ni/Au-SPE.

Huajie Shu, Qinglin Liu, Qianhui Wei, Changhui Mao, Feng Wei, Hailing Tu

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huajie ShuState Key Laboratory of Advanced Materials for Intelligent Sensing, GRINM Group Co., Ltd., Beijing 100088, China.
Qinglin LiuState Key Laboratory of Advanced Materials for Intelligent Sensing, GRINM Group Co., Ltd., Beijing 100088, China.
Qianhui WeiState Key Laboratory of Advanced Materials for Intelligent Sensing, GRINM Group Co., Ltd., Beijing 100088, China.
Changhui MaoState Key Laboratory of Advanced Materials for Intelligent Sensing, GRINM Group Co., Ltd., Beijing 100088, China.
Feng WeiState Key Laboratory of Advanced Materials for Intelligent Sensing, GRINM Group Co., Ltd., Beijing 100088, China.
Hailing TuState Key Laboratory of Advanced Materials for Intelligent Sensing, GRINM Group Co., Ltd., Beijing 100088, China.

Funding

Guangdong Basic and Applied Basic Research Foundation 2022A1515110327Guangdong Basic and Applied Basic Research Foundation 2024A1515110232Guangdong Provincial Association for Science and Technology SKXRC2025065Youth Fund Project of China GRINM 72082501E
6 · The paper itself

Abstract

As a promising class of catalysts for enzymatic glucose sensors, Prussian blue analogues (PBAs) exhibit exceptional biomimetic activity. However, their performance is often constrained by poor intrinsic conductivity, which typically limits their sensitivity. To address this limitation, this study presents an effective approach using direct in situ growth of PBAs on the electrode substrates, which enables the effective integration of PBA-based electrochemical systems. A porous Ni framework was first electrodeposited onto a screen-printed gold electrode substrate, followed by the reduction of Pt onto the porous Ni. Subsequently, NiFe PBA was synthesized in situ using the porous Pt/Ni structure as a sacrificial template. Functionalized with glucose oxidase (GO

Indexed as

Biosensing TechniquesFerrocyanidesGlucoseSweatElectrochemical TechniquesElectrodesGlucose OxidaseGoldHumansNickelPlatinumPorosityferric ferrocyanideFerrocyanidesGlucoseGlucose OxidaseGoldNickelPlatinumelectrochemical sensorin situ synthesisporous Pt/NiPrussian blue analoguessweat glucose biosensor

Identifiers

PMID42122629
PMCPMC13165853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.